1. Pump proton inhibitors display anti‐tumour potential in glioma
   Bihan Li et al, 2022, Cell Proliferation CrossRef
2. The genetic algorithm-aided three-stage ensemble learning method identified a robust survival risk score in patients with glioma
   Sujie Zhu et al, 2022 CrossRef
3. A novel model based on necroptosis-related genes for predicting immune status and prognosis in glioma
   Ying-Shi Yuan et al, 2022, Front. Immunol. CrossRef
4. Long-Acting Therapeutic Delivery Systems for the Treatment of Gliomas
   Smrithi Padmakumar et al, 2023, Advanced Drug Delivery Reviews CrossRef
5. The role of lysosomal peptidases in glioma immune escape: underlying mechanisms and therapeutic strategies
   Hao Liu et al, 2023, Front. Immunol. CrossRef
6. Tumor-Derived Membrane Vesicles Restrain Migration in Gliomas By Altering Collective Polarization
   Megha Jhunjhunwala et al, 2023, ACS Appl. Bio Mater. CrossRef
7. Unveiling the anti-glioma potential of a marine derivative, Fucoidan: its synergistic cytotoxicity with Temozolomide—an in vitro and in silico experimental study
   Indrani Biswas et al, 2023, 3 Biotech CrossRef
8. Forkhead box transcription factors (FOXOs and FOXM1) in glioma: from molecular mechanisms to therapeutics
   Peyman Tabnak et al, 2023, Cancer Cell Int CrossRef
9. Glioma: bridging the tumor microenvironment, patient immune profiles and novel personalized immunotherapy
   Tatiana A. Mishchenko et al, 2024, Front. Immunol. CrossRef
10. The Temozolomide–Doxorubicin paradox in Glioblastoma in vitro–in silico preclinical drug-screening
    Mariam-Eleni Oraiopoulou et al, 2024, Sci Rep CrossRef
11. PI3K Signaling Pathways as a Molecular Target for Glioblastoma Multiforme
    Andressa Letícia Lopes da Silva et al, 2024, CPPS CrossRef
12. Advances in Molecular Pathology, Diagnosis and Treatment of Spinal Cord Astrocytomas
    Zijun Zhao et al, 2024, Technol Cancer Res Treat CrossRef
13. Construction and validation of a TAMRGs prognostic signature for gliomas by integrated analysis of scRNA and bulk RNA sequencing data
    Zhicong Huang et al, 2025, Brain Research CrossRef
14. Starting points for the development of new targeted therapies for glioblastoma multiforme
    Agnieszka Rusak et al, 2025, Translational Oncology CrossRef
15. pH-Responsive Polyethylene Glycol Engagers for Enhanced Brain Delivery of PEGylated Nanomedicine to Treat Glioblastoma
    Jun-Lun Meng et al, 2025, ACS Nano CrossRef
16. PLGA Polymers and Doxorubicin for the Treatment of Malignant Gliomas in Adults: An Overview
    Vera V. Kudelkina et al, 2025, TOMCJ CrossRef